Official Title
Lymphocyte to Procalcitonin Ratio: A New Predictor of Prognosis and Mortality in Covid
Brief Summary

The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has beenproven to be an indicator of mortality as well as poor prognosis. In this study, the roleof the lymphocyte/procalcitonin ratio in predicting the hospitalization status ofpatients, detection of findings on CT, need for mechanical ventilation, mortality andsurvival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to bethe strongest predictor of mortality and poor prognosis, especially in patients over 65years of age.

Detailed Description

The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been
proven to be an indicator of mortality as well as poor prognosis. In this study, the role
of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of
patients, detection of findings on CT, need for mechanical ventilation, mortality and
survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be
the strongest predictor of mortality and poor prognosis, especially in patients over 65
years of age. The auc value, PPV and specificity of the lymphocyte/procalcitonin ratio
were higher than the lymphocyte/CRP ratio.

Active, not recruiting
COVID-19
Eligibility Criteria

Inclusion Criteria:

- Covid19 PCR test positive

Exclusion Criteria:

- Pregnancy Under 18 years old

Eligibility Gender
All
Eligibility Age
Minimum: 23 Years ~ Maximum: 100 Years
Countries
Turkey
Locations

Süleyman demirel üniversitesi tıp fakültesi
Isparta, Turkey

Furkan Ç Oğuzlar, asst. prof., Principal Investigator
suleyman demirel university faculty of medicine

Suleyman Demirel University
NCT Number
MeSH Terms
COVID-19